Herpes simplex virus induces intracellular redistribution of E2F4 and accumulation of E2F pocket protein complexes

Virology

Volumn 258, Issue 2, 1999, Pages 257-270

  Olgiate, Jennifer ^a   Ehmann, Ginger L ^a   Vidyarthi, Suman ^a   Hilton, Melissa J ^a   Bachenheimer, Steven L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ARTICLE; DNA BINDING; DNA PROTEIN COMPLEX; DNA SYNTHESIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0033526514     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9755     Document Type: Article

References (87)

1. Bedows E., Rao K. M., Welsh M. J. Fate of microfilaments in Vero cells infected with measles virus and herpes simplex virus type 1. Mol. Cell. Biol. 3:1983;712-719.
2. Beijersbergen R. L., Kerkhoven R. M., Zhu L., Carlée L., Voorhoeve P. M., Bernards R. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:1994;2680-2690.
3. Brehm A., Miska E. A., McCance D. J., Reid J. L., Bannister A. J., Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature. 391:1998;597-601.
4. Campadelli-Fiume G., Brandimarti R., Di Lazzaro C., Ward P. L., Roizman B., Torrisi M. R. Fragmentation and dispersal of Golgi proteins and glycolipids processed through Golgi following infection with herpes simplex virus. Proc. Natl. Acad. Sci. USA. 90:1993;2798-2802.
5. Chittenden T., Livingston D. M., DeCaprio J. A. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol. Cell. Biol. 13:1993;3975-3983.
6. Cobrinik D., Whyte P., Peeper D., Jacks T., Weinberg R. Cell cycle-specific association of E2F with p130 E1A-binding protein. Genes Dev. 7:1993;2392-2404.
7. de Bruyn Kops A., Knipe D. M. Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein. Cell. 55:1988;857-868.
8. de Bruyn Kops A., Knipe D. M. Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures. J. Virol. 68:1994;3512-3526.
9. 1/S-regulatory genes. Mol. Cell. Biol. 15:1995;4215-4224.
10. DeLuca N. A., Schaffer P. A. Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4. J. Virol. 62:1988;732-743.
11. Devoto S. H., Mudryj M., Pines J., Hunter T., Nevins J. R. A cyclin A-specific protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell. 68:1992;167-176.
12. Dynlacht B. D., Flores O., Lees J. A., Harlow E. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes Dev. 8:1994;1772-1786.
13. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12:1998;2245-2262.
14. Ferreira R., Magnaghi-Jaulin L., Robin P., Harel-Bellan A., Trouche D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc. Natl. Acad. Sci. USA. 95:1998;10493-10498.
15. Gao M., Knipe D. M. Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein. J. Virol. 63:1989;5258-5267.
16. Gimble J. M., Duh E., Ostrove J. M., Gendelman H. E., Max E. E., Rabson A. B. Activation of the human immunodeficiency virus long-terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NFκB/core enhancer sequence. J. Virol. 62:1988;4104-4112.
17. Ginsberg D., Vairo G., Chittenden T., Xiao Z.-X., Xu G., Wydner K. L., DeCaprio J. A., Lawrence J. B., Livingston D. M. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:1994;2665-2679.
18. Hagemeier C., Cook A., Kouzarides T. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21:1993;4998-5004.
19. Harlow E., Lane D. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Press, Cold Spring Harbor.
20. Helin K., Harlow E., Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:1993;6501-6508.
21. Helin K., Lees J. A., Vidal M., Dyson N., Harlow E., Fattaey A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 70:1992;337-350.
22. Hiebert S. W., Chellappan S. P., Horowitz J. M., Nevins J. R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:1992;177-185.
23. Hijmans E. M., Voorhoeve P. M., Beijersbergen R. L., van 't Veer L. J., Bernards R. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15:1995;3082-3089.
24. Hilton J. H., Mounghane D., McLean T., Contractor N. V., O'Neil J., Carpenter K., Bachenheimer S. L. Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor. Virology. 213:1995;624-638.
25. Ikeda M.-A., Jakoi L., Nevins J. R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA. 93:1996;3215-3220.
26. Ivey-Hoyle M., Conroy R., Huber H., Goodhart P., Oliff A., Heimbrook D. C. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13:1993;7802-7812.
27. Jang K.-L., Pulverer B., Woodgett J. R., Latchman D. S. Activation of the cellular transcription factor AP-1 in herpes simplex virus infected cells is dependent on the viral immediate-early protein ICP0. Nucleic Acids Res. 19:1991;4879-4883.
28. Johnson D. G., Schwarz J. K., Cress W. D., Nevins J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature. 365:1993;349-352.
29. Kaelin W. G., Krek W., Sellers W. R., DeCaprio J. A., Ajchanbaum F., Fuchs C. S., Chittenden T., Li Y., Farnham P. J., Blanar M. A., Livingston D. M., Flemington E. K. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 70:1992;351-364.
30. Kovesdi I., Reichel R., Nevins J. R. Identification of a cellular transcription factor involved in E1A trans-activation. Cell. 45:1986;219-228.
31. Krek W., Xu G., Livingston D. M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell. 83:1995;1149-1158.
32. Kwong A. D., Frenkel N. Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs. Proc. Natl. Acad. Sci. USA. 84:1987;1926-1930.
33. LaThangue N. B. DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:1994;108-114.
34. Lees E., Faha B., Dulic V., Reed S. I., Harlow E. Cyclin E/cdk2 and cyclinA/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6:1992;1874-1885.
35. Leone G., DeGregori J., Yan Z., Jakoi L., Ishida S., Williams R. S., Nevins J. R. E2F3 activity is regulated during the cell cycle and is required for S phase. Genes Dev. 12:1998;2120-2130.
36. Lindeman G. J., Gaubatz S., Livingston D. M., Ginsberg D. The subcellular localization of E2F-4 is cell cycle dependent. Proc. Natl. Acad. Sci. USA. 94:1997;5095-5100.
37. Lou R. X., Postigo A. A., Dean D. C. Rb interacts with histone deacetylase to repress transcription. Cell. 92:1998;463-473.
38. Magae J., Wu C.-L., Illenye S., Harlow E., Heintz N. H. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci. 109:1996;1717-1726.
39. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J. P., Troalen F., Trouche D., Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 391:1998;601-604.
40. Martin T. E., Barghusen S. C., Leaser G. P., Spear P. G. Redistribution of nuclear ribonucleoprotein antigens during herpes simplex virus infection. J. Cell Biol. 105:1987;2069-2082.
41. Maul G. G., Everett R. D. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen. Virol. 75:1994;1223-1233.
42. Maul G. G., Guldner H. H., Spivack J. G. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 74:1993;2679-2690.
43. McGregor F., Phelan A., Dunlop J., Clements J. B. Regulation of herpes simplex virus poly(A) site usage and the action of immediate-early protein IE63 in the early-late switch. J. Virol. 70:1996;1931-1940.
44. McLaughlan J., Phelan A., Loney C., Sandri-Goldin R. M., Clements J. B. Herpes simplex virus IE63 acts at the post-transcriptional level to stimulate viral mRNA 3′ processing. J. Virol. 66:1992;6939-6945.
45. Mittnacht S., Weinberg R. A. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell. 65:1991;381-393.
46. Moberg K., Starz M. A., Lees J. A. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1996;1436-1449.
47. Mudryj M., Devoto S. H., Hiebert S. W., Hunter T., Pines J., Nevins J. R. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell. 65:1991;1243-1253.
48. Müller H., Moroni M. K., Vigo E., Petersen B. O., Bartek J., Helin K. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17:1997;5508-5520.
49. Nevins J. R. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:1992;424-429.
50. Nevins J. R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:1998;585-593.
51. Norrild B., Lehto V. P., Virtanen I. Organization of cytoskeleton elements during herpes simplex virus type 1 infection of human fibroblasts: An immunofluorescence study. J. Gen. Virol. 67:1986;97-105.
52. Ohtani K., DeGregori J., Leone G., Herendeen D. R., Kelly T. J., Nevins J. R. Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol. Cell. Biol. 16:1996;6977-6984.
53. Patel. A. Hanson J., McLean T. I., Olgiate J., Hilton M., Miller W. E., Bachenheimer S. L. Herpes simplex virus type 1 induction of persistent NF-κB nuclear translocation increases the efficiency of virus replication. Virology. 247:1998;212-222.
54. Phelan A., Carmo-Fonesca M., McLaughlan J., Lamond A. I., Clements J. B. A herpes simplex virus type 1 immediate-early gene product, IE63, regulates small nuclear ribonucleoprotein distribution. Proc. Natl. Acad. Sci. USA. 90:1993;9056-9060.
55. Qin X. Q., Chittenden T., Livingston D., Kaelin W. G. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:1992;953-964.
56. Read G. S. Control of mRNA stability during herpes simplex virus infections. Harford J. B., Morris D. R. mRNA metabolism and post-transcriptional gene regulation. 1997;311-321 Wiley-Liss, New York.
57. Roizman B., Roane P. R. Jr. Multiplication of herpes simplex virus. II. The relation between protein synthesis and the duplication of viral DNA in infected Hep-2 cells. Virology. 22:1964;262-269.
58. Roizman B., Sears A. Herpes simplex viruses and their replication. Fields B. N., Knipe D. M. Virology. 1990;Raven, New York.
59. Rong B. L., Libermann T. A., Kogawa K., Ghosh S., Cao L.-X., Pavan-Langston D., Dunkel E. C. HSV-1 inducible proteins bind to NFκB-like sites in the HSV-1 genome. Virology. 189:1992;750-756.
60. Sandri-Goldin R. M., Hibbard M. K., Hardwicke M. A. The C-terminal repressor region of herpes simplex virus type 1 ICP27 is required for the redistribution of small nuclear ribonucleoprotein particles and splicing factor SC35; however these alterations are not sufficient to inhibit host cell splicing. J. Virol. 69:1995;6063-6076.
61. Sandri-Goldin R., Mendoza G. E. A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing. Genes Dev. 6:1992;848-863.
62. Sardet C., Vidal M., Cobrinik D., Geng Y., Onufryk C., Chen A., Weinberg R. A. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phase of the cell cycle. Proc. Natl. Acad. Sci. USA. 92:1995;2403-2407.
63. Scheffner M., Munger K., Byrne J. C., Howley P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA. 88:1991;5523-5527.
64. Schek N., Bachenheimer S. L. Degradation of cellular mRNAs induced by a virion-associated factor during herpes simplex virus infection of Vero cells. J. Virol. 55:1985;601-610.
65. Schwarz J. K., Devoto S. H., Smith E. J., Chellappan S. P., Jakoi L., Nevins J. R. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12:1993;1013-1020.
66. Sears R., Ohtani K., Nevins J. R. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol. Cell. Biol. 17:1997;5227-5235.
67. Sellers W. R., Rodgers J. W., Kaelin W. G. Jr. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA. 92:1995;11544-11548.
68. Shan B., Zhu X., Chen P.-L., Durfee T., Yang Y., Sharp D., Lee W.-H. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: Identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12:1992;5620-5631.
69. Sherman G., Bachenheimer S. L. DNA processing in temperature-sensitive morphogenesis mutants of HSV-1. Virology. 158:1987;427-430.
70. Shirodkar S., Ewen M., DeCaprio J. A., Morgan J., Livingston D. M., Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle regulated manner. Cell. 68:1992;157-166.
71. Smith E. J., Leone G., DeGregori J., Jakoi L., Nevins J. R. The accumulation of an E2F-p130 transcription repressor distinguishes a G0 from a G1 cell state. Mol. Cell. Biol. 16:1996;6965-6976.
72. Smith E. J., Nevins J. R. The Rb-related p107 protein can suppress E2F function independently of binding to cyclin U.C.A/ cdk2. Mol. Cell. Biol. 15:1995;338-344.
73. Starostik P., Chow K. N. B., Dean C. D. Transcriptional repression and growth suppression by the p107 pocket protein. Mol. Cell. Biol. 16:1996;3606-3614.
74. Stimac E., Housman D., Huberman J. A. Effects of inhibition of protein synthesis on DNA replication in cultured mammalian cells. J. Mol. Biol. 115:1977;485-511.
75. Strom T., Frenkel N. Effects of herpes simplex virus on mRNA stability. J. Virol. 61:1987;2198-2207.
76. Su L., Knipe D. M. Herpes simplex virus α protein ICP27 can inhibit or augment viral gene transactivation. Virology. 170:1989;496-504.
77. Vairo G., Livingston D. M., Ginsberg D. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:1995;869-881.
78. Verona R., Moberg K., Estes S., Starz M., Vernon J. P., Less J. A. E2F activity is regulated by cell-cycle-dependent changes in subcellular localization. Mol. Cell. Biol. 17:1997;7268-7282.
79. Weintraub S. J., Chow K. N. B., Luo R. X., Zhang S. H., He S., Dean D. C. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. 375:1995;812-815.
80. Weintraub S. J., Prater C. A., Dean D. C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 358:1992;259-261.
81. Wilcock D., Lane D. P. Localization of p53, retinoblastoma and host replication proteins at the sites of viral replication in herpes-infected cells. Nature. 349:1991;429-431.
82. Xu M., Sheppard K.-A., Peng C.-Y., Yee A. S., Piwnica-Worms H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14:1994;8420-8431.
83. Yao F., Schaffer P. A. An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J. Virol. 69:1995;6249-6258.
84. Zhu L., van den Heuvel S., Helin K., Fattaey A., Ewen M., Livingston D., Dyson N., Harlow E. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1993;1111-1125.
85. Zhu L., Weller S. K. The UL5 gene of herpes simplex virus type 1: Isolation of a lacZ insertion mutant and association of the UL5 gene product with other members of the helicase-primase complex. J. Virol. 66:1992;458-468.
86. Zhu Z., Cai W., Schaffer P. A. Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J. Virol. 68:1994;3027-3040.
87. Zhu Z., DeLuca N. A., Schaffer P. A. Overexpression of the herpes simplex virus type 1 immediate-early regulatory protein, ICP27, is responsible for the aberrant localization of ICP0 and mutant forms of ICP4 in ICP4 mutant virus-infected cells. J. Virol. 70:1996;5346-5356.